Patent directory · USPTO A61K / A61P
Patents matching “Ionis Pharmaceuticals, Inc.”
202 pharma patents match "Ionis Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 202 pharmaceutical patents matching "Ionis Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11530410
Methods for treating hypercholesterolemia
granted -
US 11525136
Modulators of APOL1 expression
granted -
US 11492617
Compositions and methods for modulation of protein aggregation
granted -
US 11447521
Compounds and methods for modulating angiotensinogen expression
granted -
US 11421231
Modulation of Huntington expression
granted -
US 11414657
Modified CRISPR RNA and modified single CRISPR RNA and uses thereof
granted -
US 11400161
Method of conjugating oligomeric compounds
granted -
US 11376273
Modulation of factor 11 expression
granted -
US 11365416
Modulators of EZH2 expression
granted -
US 11339393
Compositions for modulating C9ORF72 expression
granted -
US 11332746
Compounds and methods for reducing LRRK2 expression
granted -
US 11319536
Modulating apolipoprotein (a) expression
granted -
US 11312962
Modulators of diacyglycerol acyltransferase 2 (DGAT2)
granted -
US 11312964
Compositions and methods for modulating growth hormone receptor expression
granted -
US 11299736
Conjugated antisense compounds and their use
granted -
US 11299737
Compounds and methods for modulating SMN2
granted -
US 11293025
Compositions and methods for modulating Ataxin 3 expression
granted -
US 11241451
Modulators of IRF4 expression
granted -
US 11236339
Modulation of GYS1 expression
granted -
US 11236335
Selective antisense compounds and uses thereof
granted -
US 11230712
Compounds and methods for reducing SNCA expression
granted -
US 11225664
Modulation of angiopoietin-like 3 expression
granted -
US 11214803
Modulators of YAP1 expression
granted -
US 11208650
Modulators of IRF5 expression
granted